Markedly increased incidence and improved survival of testicular cancer in the Netherlands

References

• NCR. Netherlands Cancer Registry. [cited 2011 Sep 6]. Available from: http://www.cijfersoverkanker.nl
   Google Scholar
• Manecksha RP, Fitzpatrick JM. Epidemiology of testicular cancer. Br J Urol Int 2009;104:1329–33.
   Google Scholar
• Holmes L, Jr., Escalante C, Garrison O, Foldi BX, Ogungbade GO, Essien EJ, et al. Testicular cancer incidence trends in the USA (1975–2004): Plateau or shifting racial paradigm?. Public Health 2008;122:862–72.
   PubMed Web of Science ®Google Scholar
• Huyghe E, Plante P, Thonneau PF. Testicular cancer variations in time and space in Europe. Eur Urol 2007;51: 621–8.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Devesa SS, McGlynn KA, Moller H. Interpreting the international trends in testicular seminoma and nonseminoma incidence. Nature Clin Pract 2006;3: 532–43.
   PubMedGoogle Scholar
• Jacobsen R, Moller H, Thoresen SO, Pukkala E, Kjaer SK, Johansen C. Trends in testicular cancer incidence in the Nordic countries, focusing on the recent decrease in Denmark. Int J Androl 2006;29:199–204.
   PubMedGoogle Scholar
• Bray F, Richiardi L, Ekbom A, Pukkala E, Cuninkova M, Moller H. Trends in testicular cancer incidence and mortality in 22 European countries: Continuing increases in incidence and declines in mortality. Int J Cancer 2006;118:3099–111.
   PubMed Web of Science ®Google Scholar
• Verhoeven RH, Coebergh JW, Kiemeney LA, Koldewijn EL, Houterman S. Testicular cancer: Trends in mortality are well explained by changes in treatment and survival in the southern Netherlands since1970. Eur J Cancer 2007;43: 2553–8.
   PubMed Web of Science ®Google Scholar
• Einhorn LH. Curing metastatic testicular cancer. Proc Natl Acad Sci U S A 2002;99:4592–5.
   PubMed Web of Science ®Google Scholar
• van Steenbergen LN, Elferink MA, Krijnen P, Lemmens VE, Siesling S, Rutten HJ, et al. Improved survival of colon cancer due to improved treatment and detection: A nationwide population-based study in The Netherlands 1989–2006. Ann Oncol 2010;21:2206–12.
   PubMed Web of Science ®Google Scholar
• Coebergh JWW, Janssen-Heijnen MLG, Louwman WJ, Voogd AC, eds. Cancer incidence, care and survival in the South of the Netherlands, 1955-1999: A report of the Eindhoven Cancer Registry with cross border implications. Eindhoven: Comprehensive Cancer Centre South (IKZ); 2001.
   Google Scholar
• Verhoeven R, Houterman S, Kiemeney B, Koldewijn E, Coebergh JW. Testicular cancer: Marked birth cohort effects on incidence and a decline in mortality in southern Netherlands since 1970. Int J Cancer 2008;122:639–42.
   PubMed Web of Science ®Google Scholar
• Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al. International classification of diseases for oncology, 3rd ed. Geneva: World Health Organization; 2000.
   Google Scholar
• Brenner H, Gefeller O. An alternative approach to monitoring cancer patient survival. Cancer 1996;78:2004–10.
   PubMed Web of Science ®Google Scholar
• McGlynn KA, Cook MB. Etiologic factors in testicular germ-cell tumors. Future Oncol 2009;5:1389–402.
   PubMed Web of Science ®Google Scholar
• Skakkebaek NE, Rajpert-De Meyts E, Main KM. Testicular dysgenesis syndrome: An increasingly common developmental disorder with environmental aspects. Hum Reprod 2001; 16:972–8.
   PubMed Web of Science ®Google Scholar
• Wohlfahrt-Veje C, Main KM, Skakkebaek NE. Testicular dysgenesis syndrome: Foetal origin of adult reproductive problems. Clin Endocrinol 2009;71:459–65.
   PubMed Web of Science ®Google Scholar
• Thorup J, McLachlan R, Cortes D, Nation TR, Balic A, Southwell BR, et al. What is new in cryptorchidism and hypospadias – a critical review on the testicular dysgenesis hypothesis. J Pediat Surg 2010;45:2074–86.
   PubMed Web of Science ®Google Scholar
• Dieckmann KP, Pichlmeier U. Clinical epidemiology of testicular germ cell tumors. World J Urol 2004;22:2–14.
   PubMed Web of Science ®Google Scholar
• Garner MJ, Turner MC, Ghadirian P, Krewski D. Epidemiology of testicular cancer: An overview. Int J Cancer 2005;116:331–9.
   PubMed Web of Science ®Google Scholar
• Sonneveld DJ, Hoekstra HJ, Van Der Graaf WT, Sluiter WJ, Schraffordt Koops H, et al. The changing distribution of stage in nonseminomatous testicular germ cell tumours, from 1977 to 1996. Br J Urol Int 1999;84:68–74.
   Google Scholar
• Powles TB, Bhardwa J, Shamash J, Mandalia S, Oliver T. The changing presentation of germ cell tumours of the testis between 1983 and 2002. Br J Urol Int 2005;95:1197–200.
   Google Scholar
• Shah MN, Devesa SS, Zhu K, McGlynn KA. Trends in testicular germ cell tumours by ethnic group in the United States. Int J Androl 2007;30:206–13; discussion 13–4.
   PubMedGoogle Scholar
• Heimdal K, Fossa SD, Johansen A. Increasing incidence and changing stage distribution of testicular carcinoma in Norway 1970–1987. Br J Cancer 1990;62:277–8.
   PubMed Web of Science ®Google Scholar
• Casey RG, Grainger R, Butler MR, McDermott TE, Thornhill JA. Public awareness of testis cancer and the prevalence of testicular self-examination-changing patterns over 20 years. Urology 2010;76:915–8.
   PubMed Web of Science ®Google Scholar
• Krege S, Beyer J, Souchon R, Albers P, Albrecht W, Algaba F, et al. European consensus conference on diagnosis and treatment of germ cell cancer: A report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I. Eur Urol 2008;53:478–96.
   PubMed Web of Science ®Google Scholar
• Krege S, Beyer J, Souchon R, Albers P, Albrecht W, Algaba F, et al. European consensus conference on diagnosis and treatment of germ cell cancer: A report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part II. Eur Urol 2008;53:497–513.
   PubMed Web of Science ®Google Scholar
• Oncoline. [cited 2011 Sep 26]. Available from: http://www.oncoline.nl/testiscarcinoom
   Google Scholar
• Biggs ML, Schwartz SM. Chapter 21, Cancer of the testis. In: Ries LAM, Young JL, Keel GE, Eisner MP, Lin YD, Horner MJ, editors. SEER survival monograph: Cancer survival among adults: US SEER Program, 1988–2001, Patient and tumor characteristics. Bethesda, MD: National Cancer Institute, SEER Program; 2007.
   Google Scholar
• Biggs ML, Schwartz SM. Differences in testis cancer survival by race and ethnicity: A population-based study, 1973–1999 (United States). Cancer Causes Control 2004;15:437–44.
   PubMed Web of Science ®Google Scholar